Emerging growth companies experience unexpected delays. Cash flows, equipment considerations and the list goes on and on.

Cardiogenics trial test is 50% completed and will begin, IMHO, shortly.

I like to live in the present and look to the future, while others live in the past and miss the boat!

To the future!